Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses

Translated title of the contribution: Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses

G.W.K. Hugenholtz, E.R. Heerdink, J.J. Stolker, W.E.E. Meijer, A.C.G. Egberts, W.A. Nolen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionHaloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses
Original languageUndefined/Unknown
Pages (from-to)897-903
Number of pages7
JournalJournal of Clinical Psychiatry
Volume67
Issue number6
Publication statusPublished - 2006

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this